复星医药

- 600196

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2020  2019  2018  2017  2016  2015  2014  2013  2012  2011  2010 
复星医药(600196) 利润表
单位:万元
报表日期2020-03-312019-12-312019-09-302019-06-302019-03-31
一、营业总收入588,050.722,858,515.202,122,761.871,417,276.86673,001.42
营业收入588,050.722,858,515.202,122,761.871,417,276.86673,001.42
二、营业总成本557,683.252,714,763.651,985,799.771,314,852.84627,275.44
营业成本263,865.181,154,342.11853,665.75559,898.31275,100.11
营业税金及附加4,344.5125,983.6117,043.8611,651.895,894.77
销售费用168,104.84984,675.84740,603.70499,844.85226,200.33
管理费用58,645.64259,078.15180,064.57111,899.2654,310.24
财务费用13,459.7086,543.8865,419.0046,620.2125,812.75
研发费用49,263.39204,140.06129,002.8984,938.3139,362.97
资产减值损失--------122.22
公允价值变动收益-22,591.95-35,315.90-13,028.036,410.9917,072.06
投资收益64,889.40356,549.53153,747.51104,465.4332,806.45
其中:对联营企业和合营企业的投资收益20,098.07143,141.46111,850.3073,412.2030,161.27
汇兑收益----------
三、营业利润78,958.09449,355.51293,125.80221,751.4799,083.18
加:营业外收入354.537,738.236,083.71584.30291.31
减:营业外支出2,376.544,518.483,344.542,720.78943.29
其中:非流动资产处置损失----------
四、利润总额76,936.07452,575.26295,864.97219,614.9898,431.19
减:所得税费用12,087.1378,223.1450,305.2737,652.0913,347.27
五、净利润64,848.94374,352.13245,559.70181,962.8985,083.92
归属于母公司所有者的净利润57,719.80332,161.76206,370.41151,611.9871,229.17
少数股东损益7,129.1442,190.3739,189.2830,350.9113,854.76
六、每股收益
基本每股收益(元/股)0.23001.30000.81000.59000.2800
稀释每股收益(元/股)0.23001.30000.81000.59000.2800
七、其他综合收益-21,246.82-21,782.503,495.854,397.521,109.21
八、综合收益总额43,602.12352,569.63249,055.55186,360.4286,193.13
归属于母公司所有者的综合收益总额44,750.63312,840.38209,965.02154,492.3570,933.98
归属于少数股东的综合收益总额-1,148.5139,729.2539,090.5331,868.0715,259.15
下载全部历史数据到excel中 返回页顶